Dyadic to report first quarter 2024 financial results on tuesday, may 14, 2024

Jupiter, fla., april 30, 2024 (globe newswire) -- dyadic international, inc. (“dyadic”, “we”, “us”, “our”, or the “company”) (nasdaq: dyai), a biotechnology company focused on the efficient large-scale manufacture of proteins for use in human and animal vaccines and therapeutics, as well as in non-pharmaceutical applications including food, nutrition, and wellness, today announced that it will report its financial results for the first quarter 2024 and host a corporate update conference call on tuesday, may 14, 2024.
DYAI Ratings Summary
DYAI Quant Ranking